Skip to content

Therapeutic Education Consultations With Diabetic Patients Treated With Intensified Insulin Therapy

Impact of Therapeutic Education Consultations Conducted by Specialized Nurses on Glycemic Control and Quality of Life in Diabetic Patients Treated With Intensified Insulin Therapy: a Randomized Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06167499
Acronym
DIABETE COACH
Enrollment
7
Registered
2023-12-12
Start date
2024-02-09
Completion date
2025-03-01
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete Mellitus, Insulin Dependent Diabetes

Brief summary

Diabetes is a chronic condition that affects around 8% of the French population, and is associated with severe complications. Maintaining a constant blood glucose level of between 0.7 and 1.80 g/l is the day-to-day objective of diabetic patients.Insulin can be administered by injection via syringes or pens, or by insulin pumps and patients can perform self-monitoring of blood glucose. All these actions can be the subject of therapeutic education, which involves a range of tools, including dedicated individual consultations carried out by state-qualified nurses. The aim of the study is to evaluate the benefit of therapeutic education consultations conducted by nurses in addition to medical consultations, on the follow-up of diabetic patients, insulin pump carriers or treated with multiple injections, in terms of glycemic control, quality of life and medical complications. The objective of the study is to evaluate whether the therapeutic education consultations conducted by nurses can improve the care of the diabetic patient.

Interventions

OTHERDiabetes Therapeutic Education conducted by nurses

Individual consultations with the therapeutic education IDE, who will help the patient to achieve the therapeutic objectives set before the medical consultation. Once the objectives have been set, the IDE will set up individual workshops and subsequently assess the patient's learning and its impact on his or her care. These workshops can include equipment demonstrations and practical exercises, explanations of treatment adaptation protocols, and dietary or sexual advice.

Sponsors

Hopital Nord Franche-Comte
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Woman or man aged 18 to 75 * Diabetic patient type 1 or 2 insulin-dependent * Patient treated with multi-injections or insulin pump * Patient equipped with FreeStyle Libre flash glucose monitoring system * Glycemic imbalance with HBA1c \> 8 * Patient living at home

Exclusion criteria

* Recent discovery (\< 6 months) of diabetes * Major intellectual disability * Social isolation * IMC \> 35 * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Rate of glycated hemoglobin HBA1c12 monthsDifference in HBA1c between baseline and 12 months (M12)

Secondary

MeasureTime frameDescription
Evaluation of patients' satisfaction with diabetes treatment18 monthsQuestionnaire assessing satisfaction with diabetes treatment (Diabetes Treatment Satisfaction Questionnaires: DTSQs)
Evaluation of long-term complications over 18 months18 monthsAssessment of the development and evolution of diabetes-related complications: neuropathy, nephropathy, retinopathy, arteriopathy, erectile dysfunction, heart disease, hypertension, foot ulcers, amputations and cerebrovascular damage. Number of additional hospitalizations and urgent consultations for acute or chronic complications.
Evaluation of glycemic control over 18 months18 monthsEvaluation via Freestyle free blood glucose sensor with free view software every 6 months, over the last month and the last 3 months prior to medical consultation: * % of time spent in target range (0.7 g/l ≤ blood glucose ≤ 1.8g/l) * % of time spent in hypoglycemia (blood glucose \<0.7 g/l, * % of time spent in hyperglycemia (blood glucose \> 1.8g/l) Recording of ketoacidosis episodes during patient attendance Recording of episodes of severe hypoglycemia requiring third-party assistance with the patient HBA1c monitoring every 3 months
Evaluation of patients' quality of life over 18 months18 monthsQuestionnaire assessing quality of life (Audit of Diabetes Dependent Quality of Life - 19 items: ADDQoL 19)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026